Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Dominic King

Sports Medicine Cleveland, OH Doctor of Osteopathy

NPI 1780983437 CMS profile 1342432

7010 Engle Rd, Cleveland, OH 44130

Open in the dashboard

General payments

$232,563

133 records reported · program years 2019–2025

Research payments

$7,500

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Dominic King of Cleveland, OH is reported in the CMS Open Payments database as having received $232,563 across 133 general payments and $7,500 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $34,143 16
2024 General $44,913 11
2023 General $24,470 7
2022 General $25,000 18
2021 General $16,500 8
2020 General $31,652 14
2019 General $55,885 59
2019 Research $7,500 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Dominic King
  • Sports Medicine median
  • Middle half of Sports Medicine
  • National median

In program year 2025, general payments to Dominic King were reported at $34,143. Among 1,257 Sports Medicine profiles paid that year, the median was $114 and the middle half received between $39 and $293.

Show as a table
Year Dominic King Sports Medicine median Middle half National median
2019 $55,885 $119 $35–$362 $163
2020 $31,652 $77 $24–$275 $114
2021 $16,500 $104 $28–$340 $132
2022 $25,000 $94 $31–$272 $149
2023 $24,470 $91 $34–$271 $160
2024 $44,913 $126 $38–$294 $164
2025 $34,143 $114 $39–$293 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. HydroCision, Inc. $183,335 75 payments
  2. Arthrex, Inc. $28,896 50 payments
  3. CyMedica Orthopedics, Inc. $20,111 3 payments
  4. Flexion Therapeutics, Inc. $116 1 payment
  5. Alexion Pharmaceuticals, Inc. $31 1 payment
  6. Bioventus LLC $27 1 payment
  7. Otsuka America Pharmaceutical, Inc. $24 1 payment
  8. Smith+Nephew, Inc. $22 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $208,451 66 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $19,031 4 payments
  3. Travel and Lodging $3,433 22 payments
  4. Food and Beverage $1,648 41 payments
Products named General payments · program years 2019–2025
  1. TENJET Orthopedic & Spine $128,471 50 payments
  2. TenJet Orthopedic & Spine $38,364 17 payments
  3. AlloJet $38,364 17 payments
  4. SpineJet $38,364 17 payments
  5. TenJet Orthopedic & Spine $16,500 8 payments
  6. Zilretta $116 1 payment
  7. ULTOMIRIS $31 1 payment
  8. Durolane $27 1 payment
  9. REXULTI $24 1 payment
  10. EVOS $22 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Skye Orthobiologics LLC $7,500 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

15

Median for Family Practice: 1,826

Drug cost

$33

Median for Family Practice: $120,094

Branded share of claims

0%

Median for Family Practice: 18.9%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Meloxicam Generic 15 $33

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 105,120 Part D prescribers listed as Family Practice; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 24 billing codes

Paid by Medicare

$22,187

Medicare's payments for the services billed

Medicare patients

127

Average age 75

Services billed

473

78 women, 49 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 59%
Chronic kidney disease 20%
Depression 20%
Atrial fibrillation 19%
Osteoporosis 19%
Ischemic heart disease 16%
Cancer 14%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

134 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sports Medicine in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record